Cargando…
Is SARS-CoV-2 (COVID-19) postviral olfactory dysfunction (PVOD) different from other PVOD?
BACKGROUND: The SARS-CoV-2 virus continues to spread rapidly across the globe afflicting many with Coronavirus Disease 2019 (COVID-19). As the infection rates rise, a growing number of SARS-CoV-2 positive individuals have been reported to complain of olfactory disturbances at an alarming rate. Postv...
Autores principales: | Imam, Sarah A., Lao, Wilson P., Reddy, Priyanka, Nguyen, Shaun A., Schlosser, Rodney J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
KeAi Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236684/ https://www.ncbi.nlm.nih.gov/pubmed/32837756 http://dx.doi.org/10.1016/j.wjorl.2020.05.004 |
Ejemplares similares
-
A case report of PVOD patient combined with pulmonary embolism: Anticoagulation or not?
por: Yuan, Xiaoling, et al.
Publicado: (2017) -
Sendai Virus Induces Persistent Olfactory Dysfunction in a Murine Model of PVOD via Effects on Apoptosis, Cell Proliferation, and Response to Odorants
por: Tian, Jun, et al.
Publicado: (2016) -
Sudden Death in a Patient with Pulmonary Veno-occlusive Disease (PVOD) and Severe Pulmonary Hypertension
por: Saito, Minako, et al.
Publicado: (2017) -
A Simple Method to Assess In Vivo Proliferation in Lung Vasculature with EdU: The Case of MMC-Induced PVOD in Rat
por: Fabrice, Antigny, et al.
Publicado: (2015) -
Good response to PAH-targeted drugs in a PVOD patient carrying Biallelic EIF2AK4 mutation
por: Liang, Li, et al.
Publicado: (2018)